Development of the preventive fetal medication of which a therapeutic target is improvement of the severity of cleft palate phenotype in the cleft palate model mouse
Development of the preventive fetal medication of which a therapeutic target is improvement of the severity of cleft palate phenotype in the cleft palate model mouse
批准号:
21592349
负责人:
TAKIGAWA Toshiya
金额:
$2.91万
依托单位:
依托单位国家:
日本
项目类别:
Grant-in-Aid for Scientific Research (C)
财政年份:
2009
资助国家:
日本
项目状态:
已结题
起止时间:
2009 至 2011
中文摘要
众所周知,人类的腭裂表型是多种多样的,人们普遍认为人类腭裂的原因是由多因素理论解释的。然而,在用实验动物建立的腭裂模型中,几乎所有的腭裂表型都只表现为完全性腭裂,所以究竟是什么因素导致了人类腭裂表型的多态,以及人类腭裂表型多态的机制还有待阐明。本研究旨在通过使用转化生长因子-β3基因敲除的C57BL6/J小鼠(其纯合子胎儿仅表现为完全性腭裂)来证明表观遗传修饰物产生了多种腭裂表型。此外,本研究对使用DNA甲基转移酶抑制剂RG108的预防性胎儿药物的开发提出了挑战,其治疗目标是改善腭裂的严重程度。通过使用新开发的体外分析系统,我发现al…此外,尽管转化生长因子-β3基因缺失的C57BL6/J小鼠胚胎的腭部内侧边缘上皮(MEE)细胞不能引起上皮-间充质转化(EMT)和腭部融合,但它们可以接受空间特异性的EMT,并通过DNA甲基转移酶抑制剂RG108在体外与对侧腭部部分融合。此外,研究发现,在宫内暴露于RG108的转化生长因子-β3基因缺失的小鼠胚胎,其中一些表现为不同程度的不完全性腭裂,这与人类观察到的腭裂表型非常相似。在这个实验模型中,Igf2r正义启动子区域的DNA CG岛比内含子Igf2r反义启动子区域的DNA CG岛高度去甲基化,导致IGF2R在腭裂组织的外膜和间质中的表达比对照组更强。综合这些结果,本研究为揭示导致腭裂表型变异的表观遗传学机制提供了新的见解,并首次提出了预防性用药的可能性,其治疗靶点是改善腭裂的严重程度。较少
英文摘要
It is well known that cleft palate phenotype in humans is varied and widely accepted that the cause of human cleft palate is accountable by"multi-factorial theory". However, almost all the cleft palate phenotype in the cleft palate models using laboratory animals showed complete cleft palate only, so that what kind of factors that produce the phenotypic polymorphism of human cleft palate remains enigmatic and the mechanism underlying phenotypic polymorphism of human cleft palate wait for clarification. This study aimed to demonstrate that the epigenetic modifier produces a variety of cleft palate phenotype by using Tgf-beta 3 knockout C57BL6/J mice, whose homozygous fetuses show complete cleft palate only. Furthermore, this study challenged development of the preventive fetal medication using a DNA methyl transferase inhibitor RG108, of which therapeutic target is improvement of the severity of cleft palate phenotype. By using a newly developed in vitro analytic system, I found that al … More though palatal medial edge epithelial(MEE) cells of Tgf-beta 3-null C57BL6/J mouse fetuses have no ability to bring about epithelial-mesenchymal transformation(EMT) and palate fusion, they can undergo spatially specific EMT and partially fuse to the opposed palate by in vitro medication of a DNA methyltransferase inhibitor RG108.In addition, it was found that when the Tgf-beta 3-null mouse fetuses exposed to RG108 in utero, some of them showed variedly incomplete cleft palates, which is remarkably similar to the cleft palate phenotypes observed in humans. In this experimental model, DNA CG islands in the Igf2r sense promoter region became highly demethylated more than those in the intronic Igf2r antisense promoter region, which esulted in the strong expression of IGF2R in both of the epitheium and mesenchyme of the palatal tissues more than those in controls.Taken those results together, this study provided a new insight into the epigenetic mechanism underlying the cause of phenotypic variation of cleft palate phenotype and suggested, for the first time, the possibility of the preventive fetal medication of which a therapeutic target is improvement of the severity of cleft palate phenotype. Less
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
登录
查看更多内容
肺癌治療薬イレッサによるTGFβ3ノックアウトマウスの口蓋裂表現型の重症化抑制作用について
肺癌治疗药物易瑞沙对抑制 TGFβ3 敲除小鼠腭裂表型严重程度的影响
DOI:
--
发表时间:
2010
期刊:
影响因子:
--
作者:
[滝川俊也, 高井良招, 明坂年隆]
通讯作者:
明坂年隆
肺癌治療薬イレッサ投与によるTGFβ3ノックアウトマウスの口蓋裂表現型の重症化抑制作用について
肺癌药物易瑞莎给药对 TGFβ3 敲除小鼠腭裂表型严重程度的影响
DOI:
--
发表时间:
2010
期刊:
影响因子:
--
作者:
[滝川俊也, 明坂年隆, 高井良招]
通讯作者:
高井良招
TGFβ3ノックアウトマウスの口蓋裂表現型とマウス系統に依存した口蓋突起内側縁上皮細胞の最終分化能力との相関関係
不同品系TGFβ3敲除小鼠腭裂表型与腭突内侧缘上皮细胞终末分化能力的相关性
DOI:
--
发表时间:
2011
期刊:
影响因子:
--
作者:
[Nagai Y, Mayahara M, Suzuki O, Hisamitsu H, Nakamura M, 滝川俊也]
通讯作者:
滝川俊也
肺癌治療薬イレッサ投与によるTGFβ3遺伝子欠損マウスの口蓋裂表現型を軽症化させるための予防的胎児治療の試み
尝试通过给予肺癌药物易瑞莎进行预防性胎儿治疗,以减轻 TGFβ3 基因缺陷小鼠的腭裂表型
DOI:
--
发表时间:
2010
期刊:
影响因子:
--
作者:
[滝川俊也, 高井良招, 明坂年隆, 塩田浩平]
通讯作者:
塩田浩平
顎・顔面形態形成における癒合現象の異種性と口蓋突起の癒合における上皮細胞の分化
腭突融合过程中颌面部形态发生和上皮细胞分化的融合现象的异质性
DOI:
--
发表时间:
2009
期刊:
顕微鏡 第4巻4号
影响因子:
--
作者:
[滝川俊也]
通讯作者:
滝川俊也
共 7 条
Elucidation of the mechanism to improve the cleft palate phenotype with the molecular target drug
-
批准号:24592788
-
项目类别:Grant-in-Aid for Scientific Research (C)
-
资助金额:$3.41万
-
财政年份:2012
-
负责人:TAKIGAWA Toshiya
-
依托单位:
Development of new in vitro analytic systems to clarify the mechanism underlying normal palatogenesis and cleft palate formation
-
批准号:18590166
-
项目类别:Grant-in-Aid for Scientific Research (C)
-
资助金额:$2.62万
-
财政年份:2006
-
负责人:TAKIGAWA Toshiya
-
依托单位:
Study on the mechanisms by which cleft palate shows its phenotypic polymorphism in mice
-
批准号:16590144
-
项目类别:Grant-in-Aid for Scientific Research (C)
-
资助金额:$2.3万
-
财政年份:2004
-
负责人:TAKIGAWA Toshiya
-
依托单位:
Analysis of the mechanisms of mammalian palate and limb morphogenesis
-
批准号:12670016
-
项目类别:Grant-in-Aid for Scientific Research (C)
-
资助金额:$2.5万
-
财政年份:2000
-
负责人:TAKIGAWA Toshiya
-
依托单位:
Study on the expression of matrix-degrading enzymes and programmed cell death during mammalian development
-
批准号:10670015
-
项目类别:Grant-in-Aid for Scientific Research (C)
-
资助金额:$2.05万
-
财政年份:1998
-
负责人:TAKIGAWA Toshiya
-
依托单位:
海外基金